BioCentury

10:58 PM GMT, Sep 21, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Eylea gets expanded label, CHMP recommendation

FDA approved an sBLA from Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) to expand

Read the full 112 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.